Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/7721
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Patarrão, Rita S | en_US |
dc.contributor.author | Meneses, Maria João | en_US |
dc.contributor.author | Ghadieh, Hilda | en_US |
dc.contributor.author | Herrera, Laura | en_US |
dc.contributor.author | Duarte, Sérgio | en_US |
dc.contributor.author | Ribeiro, Rogério T | en_US |
dc.contributor.author | Raposo, João F | en_US |
dc.contributor.author | Schmitt, Verena | en_US |
dc.contributor.author | Singer, Bernhard B | en_US |
dc.contributor.author | Gastaldelli, Amalia | en_US |
dc.contributor.author | Penha-Gonçalves, Carlos | en_US |
dc.contributor.author | Najjar, Sonia M | en_US |
dc.contributor.author | Macedo, M Paula | en_US |
dc.date.accessioned | 2025-01-10T07:45:38Z | - |
dc.date.available | 2025-01-10T07:45:38Z | - |
dc.date.issued | 2024-12 | - |
dc.identifier.issn | 00142972 | - |
dc.identifier.uri | https://scholarhub.balamand.edu.lb/handle/uob/7721 | - |
dc.description.abstract | Type 2 diabetes (T2DM) and obesity are characterized by altered insulin metabolism and action. Reduced hepatic insulin clearance is increasingly recognized as a key contributor to hyperinsulinemia and insulin resistance. CEACAM1 promotes hepatic insulin clearance, and its loss in hepatocytes is associated with reduced insulin clearance in mice and men. This study examines whether CEACAM1 circulating levels reflect compromised insulin metabolism and resistance in the PREVADIAB2 cohort. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | National Library of Medicine | en_US |
dc.subject | CEACAM1 | en_US |
dc.subject | Diabetes | en_US |
dc.subject | Hepatic steatosis | en_US |
dc.subject | Hyperinsulinemia | en_US |
dc.subject | Insulin clearance | en_US |
dc.subject | Insulin resistance | en_US |
dc.title | Insights into circulating CEACAM1 in insulin clearance and disease progression: Evidence from the Portuguese PREVADIAB2 study | en_US |
dc.type | Journal Article | en_US |
dc.identifier.doi | 10.1111/eci.14344 | - |
dc.identifier.pmid | 39674875 | - |
dc.identifier.scopus | 2-s2.0-85212154159 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85212154159 | - |
dc.contributor.affiliation | Faculty of Medicine | en_US |
dc.description.volume | 54 | en_US |
dc.description.issue | S2 | en_US |
dc.date.catalogued | 2025-01-10 | - |
dc.description.status | Published | en_US |
dc.identifier.openURL | https://pmc.ncbi.nlm.nih.gov/articles/PMC11646293/ | en_US |
dc.relation.ispartoftext | European Journal of Clinical Investigation | en_US |
Appears in Collections: | Faculty of Medicine |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.